H1N1 Influenza in Pregnancy: Risks, Vaccines, and Antivirals

Pina Bozzo, Nada Djokanovic, Gideon Koren

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


When pregnant women are infected by the H1N1 influenza A virus, the consequences are more serious than they are in other groups of patients. It is imperative to vaccinate pregnant women against this virus. Unvaccinated women who come in contact with the virus should receive prophylactic antiviral therapy. The existing information on the safety of oseltamavir and zanamavir, the most used antivirals, is limited but reassuring.

Original languageEnglish
Pages (from-to)1172-1175
Number of pages4
JournalJournal of Obstetrics and Gynaecology Canada
Issue number12
StatePublished - 2009
Externally publishedYes


  • Antiviral medication
  • H1N1 influenza A
  • Influenza
  • Pregnancy
  • Vaccination


Dive into the research topics of 'H1N1 Influenza in Pregnancy: Risks, Vaccines, and Antivirals'. Together they form a unique fingerprint.

Cite this